An overview of the CCTG CO32 NEO-RT trial with Principal Investigator Dr Carl Brownn

Dr Carl Brown, Co-Chair for the CO32 trial, is a Colorectal Surgeon at St Paul's Hospital in Vancouver and the head of Surgical Oncology for the Province of British Columbia. The purpose of this study is to compare the usual approach of chemotherapy plus radiation therapy followed by limited surgery, to using a more intense combination chemotherapy treatment followed by limited surgery.

The study approach without radiation may improve patients quality of life and be equally effective at shrinking or stabilizing their cancer. Dr Brown details the trial's objectives, as well as which patients it will focus on and the innovative approaches used within it. Most importantly, he details how CO32 can advance current treatment and benefit both current and future patients forever.

#CO32 #ColorectalCancer #CCTG #CancerResearch #ClinicalTrials #Cancer #CancerTreatment #FightCancer